REPO4EU On Tour
About REPO4EU
REPO4EU is the Euro-Global Platform for Mechanism-Based Drug Repurposing – from imprecise drug therapy to AI-powered precision medicine - an ambitious initiative that will usher in a profound change to medicine and patient benefit.
Mechanism-based drug repurposing will revolutionize the way we approach drugs – it will help us find new uses for already registered drugs, increase precision and radically cut down on costs and time in the drug development process –jumping straight into clinical trials that are small, precise, innovatively designed and compliant with the highest safety and operational excellence standards.
The ultimate goal is to build and grow an industry-level European online platform for validated precision drug repurposing with a global reach. This platform will operate as the go- to data hub for key information, training resources, matchmaking and cooperation in drug repurposing, providing extensive expertise throughout the whole value chain in drug repurposing: from freedom-to-operate analysis to intellectual property protection and business development, health technology assessment, ethics and data governance considerations. REPO4EU is hosting a series of national events around the globe to get in direct contact with the community of local stakeholders (researchers, SMEs and startups, clinicians, healthcare providers, policy makers, regulators, etc.) in each of the project’s target countries.
Save the date
February 19 is the day! The event is 100% free, starts at 9 am and has a run time of approx. 3 hours.
The location
We will be gathering at Future4Care on Watt-Biopark - 8 Rue Jean Antoine De Baïf, 75013 Paris.
How to join
This is a face-to-face event but if it’s impossible for you to join in person, there will be an option to connect online. You just need to select this modality in the registration form.
Sounds interesting? Seats are limited, so fill in the registration form below or drop the organizers an email at [email protected] and get your ticket now!
A rendez-vous at DeepLife's Infinite 2026
In Paris, we will be joining forces with DeepLife, one of our French community members. DeepLife is on a mission to cure disease at the cellular level through AI-driven digital twins of cells technology.
Our event will take place in the context of Infinite 2026: Unlocking new value in existing therapies, a transformative event that explores how AI is revealing the hidden potential of existing drugs and creating unprecedented opportunities for maximizing value in today’s competitive pharmaceutical landscape. Infinite 2026 brings together industry leaders, investors, clinicians, patient advocates and researchers to explore new markets, undiscovered targets and innovative approaches to drug lifecycle management.
What are you waiting for? Join us in Paris next February 19 to enjoy a full day at the forefront of AI-driven biology, where established therapies meet cutting-edge technology to address unmet medical needs faster and more efficiently than ever before.